Beth Hecht, See Remarks at Xeris Biopharma Holdings, Inc. (XERS), sold 16,667 shares at $6.24 ($104K) on 2026-03-02, disclosed to the SEC on 2026-03-04.
Scheduled sale ($104k) by See Remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.24 | 16,567 | $103K | 99.3% |
| 2 | $7.06 | 100 | $706 | 0.7% |
| Total | $6.24 avg | 16,667 | $104K | 100% |
| Filing → |
| XERS | SELL | 2026-07-02 | $134K | — | Filing → |
| XERS | SELL | 2026-06-02 | $101K | — | Filing → |
| XERS | SELL | 2026-05-01 | $104K | — | Filing → |